Stanford University to Ban Free Lunch but Not Consultancies
Stanford University announced that it is adopting a strict conflicts of interest policy.
-
-
Antidepressants and Violence: Problems at the Interface of Medicine and Law_PLoS
Evidence of an association between violence and widely prescribed antidepressant drugs is the focus of this Infomail.
-
NIH Calls it “Serious Miscondcut” Yet Agency Takes No Disciplinary actions_LA Times
The Los Angeles Times has uncovered yet additional evidence of financial misconduct and corrupt practices at the National Institutes of Health (NIH).
-
PBS: “Bitter Pill” Based on Bloomberg Pharma’s Shameful Secret Report Airs on Friday 9/8
AIR: America’s Investigative Reports, is a new Public Broadcasting System (PBS) series whose first report, "A Bitter Pill," airs Friday, Sept. 8.
-
Psychiatry’s Most Powerful Association Feeling the Heat_SCIENCE
Psychiatry’s most powerful and influential key opinion leaders who belong to the American College of Neuropsychopharmacology (ACNP) have been caught off guard. The ACNP leadership is scrambling to overcome the scorn it has received following public disclosure about multiple breaches of ethics and professional standards of conduct. The College and…
-
Curing medical mistakes–Change the Culture of Care_ Robert Wachter, MD
Dr. Robert Wachter, author of The Truth Behind America’s Terrifying Epidemic of Medical Mistakes, provides an incisive blueprint for changing the culture in medicine. His starting point is the unexplained death of children following surgery at Stony Brook University Hospital, L.I.
-
Drug Firms Use Financial Clout To Push Industry Agenda at FDA
To gain understanding as to why lethal drugs pass FDA review, read the front page article in The Wall Street Journal (below) describing the transformation of the FDA from watchdog to lapdog.
-
Schering-Plough Pleaded Guilty to Conspiracy Fined $435 Million for Promoting Off-Label Use
The pharmaceutical industry seems to be predisposed to corporate crime– much as the Mafia is–it’s their way of doing business.
-
THE SCIENTIST–Former Head of UK Psychopharmacology says Money Didn’t Sway Dr. Nemeroff
A follow-up to news reports about the conflict of interest scandal that has engulfed not only Dr. Charles Nemeroff, former president and editor in chief of the official journal of the American College of Neuropsychopharmacology, but the College itself.
-
FDA poised to change the health & wellbeing of all Americans
An illuminating essay by Byron Richards, author of Fight for Your Health: Exposing the FDA’s Betrayal of America, should be required reading for every member of Congress before voting Yes or NO on the appointment of Dr. Andrew von Eschenbach, who is poised to head the FDA.
-
On the Toxicity of Chemotherapy for Breast Cancer-the Need for Vigilance
A study published in The Journal of the National Cancer Institute, found that advanced chemotherapy put patients at far greater
risks of harm than adverse effect reports from clinical trial data reveal. -
ACNP Journal Editor Quits Amid Exposure of Conflicts of Interest
A notice from The American College of Neuropsychopharmacology, the inner sanctum of biological–predominantly drug-centered psychiatry–informs the
membership of the resignation of Dr. Charles Nemeroff, the Editor-in-Chief of its journal, Neuropsychopharmacology.